Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects

ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN HYPERTENSION: METABOLIC SYNDROME REVISITED

(2020) Alexandre A. da Silva et al.   CANADIAN JOURNAL OF CARDIOLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Low urine pH predicts new onset of diabetes mellitus during a 10‐year period in male subjects: BOREAS‐DM1 Study

(2020) Yukimura Higashiura et al.   Journal of Diabetes Investigation

U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2

(2020) Kazuma Mori et al.   HYPERTENSION RESEARCH

Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes

(2020) Nobuo Sasaki et al.   BMJ Open Diabetes Research & Care

The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010–2011

(2019) Ah Reum Khang et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

(2019) Satoshi Umemura et al.   HYPERTENSION RESEARCH

Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study

(2019) Matthieu Wargny et al.   PLoS One

Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population

(2018) Masato Furuhashi et al.   CIRCULATION JOURNAL

Fatty liver index predicts incident diabetes in a Japanese general population with and without impaired fasting glucose

(2018) Aya Hirata et al.   HEPATOLOGY RESEARCH

Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study

(2018) Josep Franch-Nadal et al.   PLoS One

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines

(2018) Masato Furuhashi et al.   Journal of Diabetes Investigation

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2017) Paul K. Whelton et al.   HYPERTENSION

Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies

(2017) Fabrice Bonnet et al.   JOURNAL OF HYPERTENSION

Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance

(2017) Ruth C. R. Meex et al.   Nature Reviews Endocrinology

2. Classification and Diagnosis of Diabetes

(2016)   DIABETES CARE

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

(2016) Luca Valenti et al.   LIVER INTERNATIONAL

Evaluating Discrimination of Risk Prediction Models

(2015) Michael J. Pencina et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetes and Hypertension: A Comparative Review of Current Guidelines

(2015) Michael J. Cryer et al.   Journal of Clinical Hypertension

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese

(2015) Xiaolin Huang et al.   MEDICINE

External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan

(2015) Bi-Ling Yang et al.   PLoS One

A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study

(2015) Ji Hye Huh et al.   PLoS One

A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)

(2014) Munkhzul Otgonsuren et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

(2012) György Baffy et al.   JOURNAL OF HEPATOLOGY

The role of angiotensin II in nonalcoholic steatohepatitis

(2012) E. Matthew Morris et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase

(2011) Alejandro López-Suárez et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study

(2011) Neeraj Bhala et al.   HEPATOLOGY

Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale

(2011) Junko Tanaka et al.   INTERVIROLOGY

Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?

(2010) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study

(2010) Katharina Lau et al.   JOURNAL OF HYPERTENSION

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES